Dynamics of hepatitis B virus infection in vivo
References (32)
- et al.
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
Hepatology
(1996) - et al.
Biochemical pharmacology of (+)- and (−)2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B virus agents
J Biol Chem
(1992) Evaluation and propagation of confidence intervals in nonlinear, asymmetrical variance spaces: analysis of ligand-binding data
Biophys J
(1983)- et al.
Randomized, controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis
Gastroenterology
(1984) - et al.
Nucleoside analogs in the treatment of chronic viral hepatitis: efficiency and complications
J Hepatol
(1994) - et al.
Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase vitro
J Biol Chem
(1992) - et al.
Reverse transcriptases and genomic variability: the accuracy of DNA replication in enzyme specific and sequence dependent
EMBO J
(1990) - et al.
The molecular biology of the hepatitis B viruses
Annu Rev Biochem
(1981) - et al.
Molecular virology and pathogenesis of hepatitis B
Lancet
(1993) - et al.
Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver
Hepatology
(1981)
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy
Science
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Nature
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time
Science
Viral dynamics in human immunodeficiency virus type 1 infection
Nature
Inhibition of the replication of hepatitiss B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues
Proc Natl Acad Sci USA
Mechanism of inhibition of duck hepatitis B virus polymerase by (−)-beta-L-2′,3′-dideoxy-3′-thiacytidine
Antimicrob Agents Chemother
Cited by (103)
Within-host mathematical models of hepatitis B virus infection: Past, present, and future
2019, Current Opinion in Systems BiologyCitation Excerpt :For example, the half-lives of serum HBV DNA and productively infected cells were estimated as ∼1 day and ∼10–100 days, respectively [25–28]. The HBV DNA production rate was also estimated to be at least 1013 virions per day during acute HBV infection [28] and at least 1011 virions per day during CHB [27]. Additional mathematical models have been formulated to capture more complex patterns of serum HBV DNA decay during therapy [30–33].
Predictors of relapse after cessation of nucleos(t)ide analog treatment in HBeAg-negative chronic hepatitis B patients: A meta-analysis
2019, International Journal of Infectious DiseasesThe intracellular dynamics of hepatitis B virus (HBV) replication with reproduced virion "re-cycling"
2016, Journal of Theoretical BiologyA mathematical model of the intracellular replication and within host evolution of hepatitis type B virus: Understanding the long time course of chronic hepatitis
2011, Journal of Theoretical BiologyCitation Excerpt :The mechanism of the persistence of HBV infection has not been fully elucidated. The viral kinetics of HBV in chronic infection is quite different from that in acute hepatitis (Zeuzem et al., 1997; Whalley et al., 2001; Pawlotsky, 2003). In acute hepatitis patient, HBV DNA rapidly replicates to the order of 109 copies/ml.
A Lyapunov functional for a stage-structured predatorprey model with nonlinear predation rate
2010, Nonlinear Analysis: Real World Applications